In patients who developed AKI using standard functional criteria (SCr and UOP) according to KDIGO staging, the addition of urinary TIMP-2•IGFBP7 >2.0 (ng/ml)2/1000 identified patients with lower 30-day survival within the functional stages. This evidence concerns the gene IGFBP7 and acute kidney injury.